Related Experiment Video
Updated: Jan 14, 2026
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Differential Effects of Aerobic, Resistance, and Combined Trainings on First- and Second-Phase Insulin Secretion and
Elaheh Piralaiy1, Alireza Rashidpour1, Badrkhan Rashwan Ismael1
1Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, University of Tabriz, Tabriz, Iran.
Objective:
This randomized controlled trial evaluated the differential effects of aerobic training (AT), resistance training (RT), and combined training (CT) on biphasic insulin secretion and glucose effectiveness (GE) in patients with Type 2 diabetes mellitus (T2DM).
Methods:
Forty-five male T2DM patients (mean age: 55.24 ± 8.17 years; disease duration: 12.51 ± 6.46 years; baseline HbA1c: 7.1% ± 1.0%) were randomized to 12-week AT (n = 11), RT (n = 11), CT (n = 11), or control (n = 12) groups. AT involved progressive aerobic exercise (25-45 min at 70%-75% maximum heart rate, thrice weekly). RT comprised nine multijoint exercises (2-3 sets, 8-12 repetitions, thrice weekly). CT combined the full AT protocol with a modified RT regimen (one set, twice weekly). First-phase insulin secretion (FPIS), second-phase insulin secretion (SPIS), and GE were quantified using validated models pre- and postintervention.
Results:
Adjusting for baseline values, age, and diabetes duration, ANCOVA revealed significant between-group differences in FPIS (F[3, 38] = 8.64, p < 0.001, η 2 = 0.406), SPIS (F[3, 38] = 6.93, p < 0.001, η 2 = 0.354), and GE (F[3, 38] = 5.57, p = 0.003, η 2 = 0.305). CT elicited the greatest improvements: FPIS (53.4% ± 12.7%, p < 0.001), SPIS (38.9% ± 11.2%, p < 0.001), and GE (12.8% ± 4.6%, p = 0.001) versus control. AT enhanced FPIS (32.6% ± 10.3%, p = 0.001) and SPIS (21.7% ± 8.9%, p = 0.042), while RT improved FPIS (28.5% ± 9.8%, p = 0.006), SPIS (27.5% ± 9.4%, p = 0.012), and GE (10.7% ± 4.3%, p = 0.004). Regression analysis identified baseline β-cell function (β = -0.31, p = 0.020), adiposity reduction (β = -0.36, p = 0.008), and glycemic improvement (β = -0.42, p = 0.003) as predictors of FPIS gains (R 2 = 0.537).
Conclusions:
CT outperforms single-modality training in enhancing biphasic insulin secretion and GE in T2DM, supporting multimodal exercise as a cornerstone of diabetes management to improve β-cell function and glycemic control.
Trial Registration:
ClinicalTrials.gov identifier: IRCT2016042227529N1.
More Related Videos
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
01:22Diabetes Mellitus: Type 2 and Gestational
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...